Hyperfine, Inc. (HYPR) Stock Grade

About Hyperfine, Inc.'s fundamentals

Hyperfine is a medical device company with a market capitalization of $70.4 million that generated 5.2% year-over-year revenue growth in its latest reporting period. However, the company is currently unprofitable, reporting a net margin of -262.3% and posting a net loss in its most recent annual statement, indicating it is burning through capital faster than it is generating revenue. The company does not pay a dividend, and standard profitability metrics like price-to-earnings and return on equity are not applicable given its loss-making status.